Ipsen SA, the French speciality biopharmaceutical company listed on Euronext Paris, has published its monthly disclosure of voting rights and share capital figures as at 31 October 2026, in accordance with French regulatory requirements. The announcement confirms a total of 83,814,526 shares composing the share capital and sets out both gross and net voting rights totals. The disclosure is a standard regulatory obligation under Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers. Investors and institutional shareholders use these monthly figures to monitor threshold crossings and assess governance-related changes at the company.

Key Points

  • Ipsen SA (Euronext Paris: 0MH6, ISIN: FR0010259150)
  • Ipsen has disclosed its total share capital and voting rights figures as at 31 October 2026
  • Total shares: 83,814,526; Gross voting rights: 132,059,377; Net voting rights: 130,677,690
  • Investors should watch for any threshold crossings calculated on the basis of the gross voting rights total

Ipsen's October 2026 Share Capital Stands at 83,814,526 Shares

As at 31 October 2026, Ipsen SA's share capital comprises 83,814,526 shares, as confirmed in the company's monthly regulatory filing. This figure forms the foundation for calculating shareholders' proportional interests in the company and is disclosed each month in line with French commercial law. The announcement was made under the company's LEI reference 549300M6SGDPB4Z94P11 and published to Euronext Paris, where Ipsen's shares are traded. No changes to the number of shares relative to prior months were commented upon by the company within this particular filing.

Gross and Net Voting Rights Figures Reflect Double Voting Rights and Treasury Shares

The October 2026 disclosure shows a gross total of 132,059,377 voting rights and a net total of 130,677,690 voting rights. The difference between these two figures arises from shares that carry no voting rights, which are excluded from the net calculation. The gross total incorporates shares benefiting from double voting rights as well as treasury shares held by the company, and it is this gross figure that serves as the reference basis for determining whether shareholders have crossed statutory or regulatory ownership thresholds, as required under French market regulation.

Regulatory Obligation Under French Commercial Code and AMF General Regulation

The filing satisfies Ipsen's obligations under Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers, France's financial markets regulator. Ipsen also notes the existence of a statutory clause in its articles requiring disclosure of threshold crossings beyond the standard legal thresholds, as referenced in Article 10 of its statutes. This additional obligation means certain shareholders may face a lower trigger point for mandatory notification than would otherwise apply under the default French legal framework.

What the Monthly Voting Rights Disclosure Means for Ipsen Shareholders

Monthly voting rights disclosures are routine regulatory filings for companies listed in France, but they carry practical significance for major shareholders and institutional investors tracking their proportional stakes. The gross voting rights total of 132,059,377 is the operative figure for threshold calculations, meaning any investor whose holding relative to this number crosses a statutory or company-specific threshold must file a declaration. Investors may be watching whether the composition of voting rights changes materially in forthcoming monthly disclosures, which could signal share buyback activity or shifts in the register.